Breaking through a roadblock in prostate cancer research: An update on human model systems

Journal of Steroid Biochemistry and Molecular Biology

Volumn 131, Issue 3-5, 2012, Pages 122-131

  Toivanen, R ^a   Taylor, R A ^a   Pook, D W ^a   Ellem, S J ^a   Risbridger, G P ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

Immuno compromised mice; Prostate cancer; Stromal niche; Tissue recombination; Xenografting

Indexed keywords

ABIRATERONE; ANDROGEN RECEPTOR; BIOLOGICAL MARKER; CYTOCHROME P450 17; EPIDERMAL GROWTH FACTOR RECEPTOR 2; PROSTATE SPECIFIC ANTIGEN; TRASTUZUMAB;

ADVANCED CANCER; ANDROGEN DEPRIVATION THERAPY; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; CANCER CELL CULTURE; CANCER GROWTH; CANCER MODEL; CELL SURVIVAL; DISEASE COURSE; DRUG SCREENING; FOLLOW UP; GENE MUTATION; GLEASON SCORE; HUMAN; IN VITRO STUDY; IN VIVO STUDY; METASTASIS; NONHUMAN; ORTHOTOPIC TRANSPLANTATION; PROSTATE CANCER; PROTEIN EXPRESSION; REVIEW; TRANSLATIONAL RESEARCH; TUMOR XENOGRAFT;

ANIMALS; ANTINEOPLASTIC AGENTS, HORMONAL; CELL LINE, TRANSFORMED; CELL LINE, TUMOR; DRUG RESISTANCE, NEOPLASM; HORMONE ANTAGONISTS; HUMANS; MALE; MODELS, BIOLOGICAL; NEOPLASM TRANSPLANTATION; PROSTATIC NEOPLASMS; TRANSLATIONAL MEDICAL RESEARCH; TUMOR CELLS, CULTURED; TUMOR MICROENVIRONMENT; XENOGRAFT MODEL ANTITUMOR ASSAYS;

ANIMALIA; MUS;

EID: 84862882302     PISSN: 09600760     EISSN: 18791220     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2012.01.005     Document Type: Review

References (80)

1. A. Jemal, R. Siegel, J. Xu, and E. Ward Cancer statistics, 2010 CA. Cancer J. Clin. 60 5 2010 277 300
2. D.C. Miller, C.S. Saigal, and M.S. Litwin The demographic burden of urologic diseases in America Urol. Clin. North Am. 36 1 2009 11 27 v
3. K.J. Pienta, C. Abate-Shen, D.B. Agus, R.M. Attar, L.W. Chung, N.M. Greenberg, W.C. Hahn, J.T. Isaacs, N.M. Navone, D.M. Peehl, J.W. Simons, D.B. Solit, H.R. Soule, T.A. VanDyke, M.J. Weber, L. Wu, and R.L. Vessella The current state of preclinical prostate cancer animal models Prostate 68 6 2008 629 639
4. C.A. O'Brien, A. Pollett, S. Gallinger, and J.E. Dick A human colon cancer cell capable of initiating tumour growth in immunodeficient mice Nature 445 7123 2007 106 110
5. S.A. Hubbard, A.M. Friel, B. Kumar, L. Zhang, B.R. Rueda, and C.E. Gargett Evidence for cancer stem cells in human endometrial carcinoma Cancer Res. 69 21 2009 8241 8248
6. E. Quintana, M. Shackleton, M.S. Sabel, D.R. Fullen, T.M. Johnson, and S.J. Morrison Efficient tumour formation by single human melanoma cells Nature 456 7222 2008 593 598
7. M.E. Kaighn, K.S. Narayan, Y. Ohnuki, J.F. Lechner, and L.W. Jones Establishment and characterization of a human prostatic carcinoma cell line (PC-3) Invest. Urol. 17 1 1979 16 23
8. J. Horoszewicz, S. Leong, T. Chu, Z. Wajsman, M. Friedman, L. Papsidero, U. Kim, L. Chai, S. Kakati, S. Arya, and A. Sandberg The LNCaP cell line - a new model for studies on human prostatic carcinoma Prog. Clin. Biol. Res. 37 1980 115 132
9. K.R. Stone, D.D. Mickey, H. Wunderli, G.H. Mickey, and D.F. Paulson Isolation of a human prostate carcinoma cell line (DU145) Int. J. Cancer 21 1978 274 281
10. J.A. Locke, E.S. Guns, A.A. Lubik, H.H. Adomat, S.C. Hendy, C.A. Wood, S.L. Ettinger, M.E. Gleave, and C.C. Nelson Androgen levels increase by intratumoral de novo steroidogenesis during progression of castration-resistant prostate cancer Cancer Res. 68 15 2008 6407 6415
11. R.E. Sobel, and M.D. Sadar Cell lines used in prostate cancer research: a compendium of old and new lines - part 2 J. Urol. 173 2 2005 360 372
12. R.E. Sobel, and M.D. Sadar Cell lines used in prostate cancer research: a compendium of old and new lines - part 1 J. Urol. 173 2 2005 342 359
13. M.M. Shen, and C. Abate-Shen Molecular genetics of prostate cancer: new prospects for old challenges Genes Dev. 24 18 2010 1967 2000
14. D.M. Peehl Primary cell cultures as models of prostate cancer development Endocr. Relat. Cancer 12 1 2005 19 47
15. Y. Wang, H. Xue, J.C. Cutz, J. Bayani, N.R. Mawji, W.G. Chen, L.J. Goetz, S.W. Hayward, M.D. Sadar, C.B. Gilks, P.W. Gout, J.A. Squire, G.R. Cunha, and Y.Z. Wang An orthotopic metastatic prostate cancer model in SCID mice via grafting of a transplantable human prostate tumor line Lab. Invest. 85 11 2005 1392 1404
16. A.Y. Liu, M.P. Roudier, and L.D. True Heterogeneity in primary and metastatic prostate cancer as defined by cell surface CD profile Am. J. Pathol. 165 5 2004 1543 1556
17. L.E. Pascal, R.Z. Vencio, L.S. Page, E.S. Liebeskind, C.P. Shadle, P. Troisch, B. Marzolf, L.D. True, L.E. Hood, and A.Y. Liu Gene expression relationship between prostate cancer cells of Gleason 3, 4 and normal epithelial cells as revealed by cell type-specific transcriptomes BMC Cancer 9 2009 452
18. W.J. Huss, D.R. Gray, E.S. Werdin, W.K. Funkhouser, and G.J. Smith Jr. Evidence of pluripotent human prostate stem cells in a human prostate primary xenograft model Prostate 60 2 2004 77 90
19. W.M. van Weerden, C. Bangma, and R. de Wit Human xenograft models as useful tools to assess the potential of novel therapeutics in prostate cancer Br. J. Cancer 100 1 2009 13 18
20. Y. Wang, M. Revelo, D. Sudilovsky, M. Cao, W. Chen, L. Goetz, H. Xue, M. Sadar, S. Shappell, G. Cunha, and S. Hayward Development and characterization of efficient xenograft models for benign and malignant human prostate tissue Prostate 64 2 2005 149 159
21. L.A. Lopez-Barcons Human prostate cancer heterotransplants: a review on this experimental model Asian J. Androl. 12 4 2010 509 518
22. N. Craft, C. Chhor, C. Tran, A. Belldegrun, J. DeKernion, O.N. Witte, J. Said, R.E. Reiter, and C.L. Sawyers Evidence for clonal outgrowth of androgen-independent prostate cancer cells from androgen-dependent tumors through a two-step process Cancer Res. 59 19 1999 5030 5036
23. L. Patrawala, T. Calhoun-Davis, R. Schneider-Broussard, and D.G. Tang Hierarchical organization of prostate cancer cells in xenograft tumors: the CD44+alpha2beta1+cell population is enriched in tumor-initiating cells Cancer Res. 67 14 2007 6796 6805
24. K.A. Klein, R.E. Reiter, J. Redula, H. Moradi, X.L. Zhu, A.R. Brothman, D.J. Lamb, M. Marcelli, A. Belldegrun, O.N. Witte, and C.L. Sawyers Progression of metastatic human prostate cancer to androgen independence in immunodeficient SCID mice Nat. Med. 3 4 1997 402 408
25. W.J. Ellis, R.L. Vessella, K.R. Buhler, F. Bladou, L.D. True, S.A. Bigler, D. Curtis, and P.H. Lange Characterization of a novel androgen-sensitive, prostate-specific antigen-producing prostatic carcinoma xenograft: LuCaP 23 Clin. Cancer Res. 2 6 1996 1039 1048
26. D.R. McCulloch, K. Opeskin, E.W. Thompson, and E.D. Williams BM18: A novel androgen-dependent human prostate cancer xenograft model derived from a bone metastasis Prostate 65 1 2005 35 43
27. T.G. Pretlow, S.R. Wolman, M.A. Micale, R.J. Pelley, E.D. Kursh, M.I. Resnick, D.R. Bodner, J.W. Jacobberger, C.M. Delmoro, and J.M. Giaconia Xenografts of primary human prostatic carcinoma J. Natl. Cancer Inst. 85 5 1993 394 398
28. W.M. van Weerden, C.M. de Ridder, C.L. Verdaasdonk, J.C. Romijn, T.H. van der Kwast, F.H. Schroder, and G.J. van Steenbrugge Development of seven new human prostate tumor xenograft models and their histopathological characterization Am. J. Pathol. 149 3 1996 1055 1062
29. S.C. Presnell, E.S. Werdin, S. Maygarden, J.L. Mohler, and G.J. Smith Establishment of short-term primary human prostate xenografts for the study of prostate biology and cancer Am. J. Pathol. 159 3 2001 855 860
30. H. Zhao, R. Nolley, Z. Chen, and D.M. Peehl Tissue slice grafts: an in vivo model of human prostate androgen signaling Am. J. Pathol. 177 1 2010 229 239
31. C. Priolo, M. Agostini, N. Vena, A.H. Ligon, M. Fiorentino, E. Shin, A. Farsetti, A. Pontecorvi, E. Sicinska, and M. Loda Establishment and genomic characterization of mouse xenografts of human primary prostate tumors Am. J. Pathol. 176 2010 1901 1913
32. S.J. McPherson, S. Hussain, P. Balanathan, S.L. Hedwards, B. Niranjan, M. Grant, U.P. Chandrasiri, R. Toivanen, Y. Wang, R.A. Taylor, and G.P. Risbridger Estrogen receptor-beta activated apoptosis in benign hyperplasia and cancer of the prostate is androgen independent and TNFalpha mediated Proc. Natl. Acad. Sci. U.S.A. 107 7 2010 3123 3128
33. D.W. Doxsee, P.W. Gout, T. Kurita, M. Lo, A.R. Buckley, Y. Wang, H. Xue, C.M. Karp, J.C. Cutz, G.R. Cunha, and Y.Z. Wang Sulfasalazine-induced cystine starvation: potential use for prostate cancer therapy Prostate 67 2 2007 162 171
34. R. Toivanen, D.M. Berman, H. Wang, J. Pedersen, M. Frydenberg, A.K. Meeker, S.J. Ellem, G.P. Risbridger, and R.A. Taylor Brief report - a bioassay to identify primary human prostate cancer repopulating cells Stem Cells 29 2011 1310 1314
35. A.S. Goldstein, J. Huang, C. Guo, I.P. Garraway, and O.N. Witte Identification of a cell of origin for human prostate cancer Science 329 5991 2010 568 571
36. K.G. Leong, B.E. Wang, L. Johnson, and W.Q. Gao Generation of a prostate from a single adult stem cell Nature 456 7223 2008 804 808
37. D.J. Mulholland, L. Xin, A. Morim, D. Lawson, O. Witte, and H. Wu Lin-Sca-1+CD49f high stem/progenitors are tumor-initiating cells in the Pten-null prostate cancer model Cancer Res. 69 22 2009 8555 8562
38. D.A. Lawson, Y. Zong, S. Memarzadeh, L. Xin, J. Huang, and O.N. Witte Basal epithelial stem cells are efficient targets for prostate cancer initiation Proc. Natl. Acad. Sci. U.S.A. 107 6 2010 2610 2615
39. R.A. Taylor, and G.P. Risbridger Prostatic tumor stroma: a key player in cancer progression Curr. Cancer Drug Targets 8 6 2008 490 497
40. S.W. Hayward Approaches to modeling stromal-epithelial interactions J. Urol. 168 3 2002 1165 1172
41. R.A. Stephenson, C.P. Dinney, K. Gohji, N.G. Ordonez, J.J. Killion, and I.J. Fidler Metastatic model for human prostate cancer using orthotopic implantation in nude mice J. Natl. Cancer Inst. 84 12 1992 951 957
42. A.F. Olumi, G.D. Grossfeld, S.W. Hayward, P.R. Carroll, T.D. Tlsty, and G.R. Cunha Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium Cancer Res. 59 19 1999 5002 5011
43. G.R. Cunha, S.W. Hayward, and Y.Z. Wang Role of stroma in carcinogenesis of the prostate Differentiation 70 9-10 2002 473 485
44. L.W. Chung, H.E. Zhau, and J.Y. Ro Morphologic and biochemical alterations in rat prostatic tumors induced by fetal urogenital sinus mesenchyme Prostate 17 2 1990 165 174
45. E.M. Schaeffer, L. Marchionni, Z. Huang, B. Simons, A. Blackman, W. Yu, G. Parmigiani, and D.M. Berman Androgen induced programs for prostate epithelial growth and invasion arise in embryogenesis and are reactivated in cancer Oncogene 27 57 2008 7180 7191
46. C.P. Liao, H. Adisetiyo, M. Liang, and P. Roy-Burman Cancer-associated fibroblasts enhance the gland-forming capability of prostate cancer stem cells Cancer Res. 70 2010 7294 7303
47. A.H. Klopp, A. Gupta, E. Spaeth, M. Andreeff, and F. Marini 3rd Concise review: dissecting a discrepancy in the literature: do mesenchymal stem cells support or suppress tumor growth? Stem Cells 29 1 2011 11 19
48. V.R. Placencio, X. Li, T.P. Sherrill, G. Fritz, and N.A. Bhowmick Bone marrow derived mesenchymal stem cells incorporate into the prostate during regrowth PLoS One 5 9 2010 e12920
49. M. Pelleitier, and S. Montplaisir The nude mouse: a model of deficient T-cell function Methods Achiev. Exp. Pathol. 7 1975 149 166
50. R.P. Custer, G.C. Bosma, and M.J. Bosma Severe combined immunodeficiency (SCID) in the mouse. Pathology, reconstitution, neoplasms Am. J. Pathol. 120 3 1985 464 477
51. P. Mombaerts, J. Iacomini, R.S. Johnson, K. Herrup, S. Tonegawa, and V.E. Papaioannou RAG-1-deficient mice have no mature B and T lymphocytes Cell 68 5 1992 869 877
52. M.J. Bosma B and T cell leakiness in the scid mouse mutant Immunodefic. Rev. 3 4 1992 261 276
53. A.M. Carroll, R.R. Hardy, J. Petrini, and M.J. Bosma T cell leakiness in scid mice Curr. Top. Microbiol. Immunol. 152 1989 117 123
54. M. Prochazka, H.R. Gaskins, L.D. Shultz, and E.H. Leiter The nonobese diabetic scid mouse: model for spontaneous thymomagenesis associated with immunodeficiency Proc. Natl. Acad. Sci. U.S.A. 89 8 1992 3290 3294
55. S. Nonoyama, F.O. Smith, I.D. Bernstein, and H.D. Ochs Strain-dependent leakiness of mice with severe combined immune deficiency J. Immunol. 150 9 1993 3817 3824
56. L.D. Shultz, P.A. Schweitzer, S.W. Christianson, B. Gott, I.B. Schweitzer, B. Tennent, S. McKenna, L. Mobraaten, T.V. Rajan, and D.L. Greiner Multiple defects in innate and adaptive immunologic function in NOD/LtSz-scid mice J. Immunol. 154 1 1995 180 191
57. M. Ito, H. Hiramatsu, K. Kobayashi, K. Suzue, M. Kawahata, K. Hioki, Y. Ueyama, Y. Koyanagi, K. Sugamura, K. Tsuji, T. Heike, and T. Nakahata NOD/SCID/gamma(c)(null) mouse: an excellent recipient mouse model for engraftment of human cells Blood 100 9 2002 3175 3182
58. L.D. Shultz, F. Ishikawa, and D.L. Greiner Humanized mice in translational biomedical research Nat. Rev. Immunol. 7 2 2007 118 130
59. T. Schatton, G.F. Murphy, N.Y. Frank, K. Yamaura, A.M. Waaga-Gasser, M. Gasser, Q. Zhan, S. Jordan, L.M. Duncan, C. Weishaupt, R.C. Fuhlbrigge, T.S. Kupper, M.H. Sayegh, and M.H. Frank Identification of cells initiating human melanomas Nature 451 7176 2008 345 349
60. N.J. Maitland, F.M. Frame, E.S. Polson, J.L. Lewis, and A.T. Collins Prostate cancer stem cells: do they have a basal or luminal phenotype? Horm. Cancer 2 1 2011 47 61
61. C. De Nunzio, G. Kramer, M. Marberger, R. Montironi, W. Nelson, F. Schroder, A. Sciarra, and A. Tubaro The controversial relationship between benign prostatic hyperplasia and prostate cancer: the role of inflammation Eur. Urol. 60 1 2011 106 117
62. R.A. Moore Inflammation of the prostate gland J. Urol. 38 1937 137 182
63. G. Penna, B. Fibbi, S. Amuchastegui, C. Cossetti, F. Aquilano, G. Laverny, M. Gacci, C. Crescioli, M. Maggi, and L. Adorini Human benign prostatic hyperplasia stromal cells as inducers and targets of chronic immuno-mediated inflammation J. Immunol. 182 7 2009 4056 4064
64. G.E. Steiner, U. Stix, A. Handisurya, M. Willheim, A. Haitel, F. Reithmayr, D. Paikl, R.C. Ecker, K. Hrachowitz, G. Kramer, C. Lee, and M. Marberger Cytokine expression pattern in benign prostatic hyperplasia infiltrating T cells and impact of lymphocytic infiltration on cytokine mRNA profile in prostatic tissue Lab. Invest. 83 8 2003 1131 1146
65. A.M. De Marzo, E.A. Platz, S. Sutcliffe, J. Xu, H. Gronberg, C.G. Drake, Y. Nakai, W.B. Isaacs, and W.G. Nelson Inflammation in prostate carcinogenesis Nat. Rev. Cancer 7 4 2007 256 269
66. W.G. Nelson, A.M. De Marzo, T.L. DeWeese, and W.B. Isaacs The role of inflammation in the pathogenesis of prostate cancer J. Urol. 172 5 (Pt 2) 2004 S6 S11 (discussion S11-S12)
67. F. Macchiarini, M.G. Manz, A.K. Palucka, and L.D. Shultz Humanized mice: are we there yet? J. Exp. Med. 202 10 2005 1307 1311
68. T. Pearson, D.L. Greiner, and L.D. Shultz Humanized SCID mouse models for biomedical research Curr. Top. Microbiol. Immunol. 324 2008 25 51
69. M. Suggitt, and M.C. Bibby 50 years of preclinical anticancer drug screening: empirical to target-driven approaches Clin. Cancer Res. 11 3 2005 971 981
70. G. Damia, and M. D'Incalci Contemporary pre-clinical development of anticancer agents - what are the optimal preclinical models? Eur. J. Cancer 45 16 2009 2768 2781
71. S.E. Barrie, G.A. Potter, P.M. Goddard, B.P. Haynes, M. Dowsett, and M. Jarman Pharmacology of novel steroidal inhibitors of cytochrome P450(17) alpha (17 alpha-hydroxylase/C17-20 lyase) J. Steroid Biochem. Mol. Biol. 50 5-6 1994 267 273
72. C. Tran, S. Ouk, N.J. Clegg, Y. Chen, P.A. Watson, V. Arora, J. Wongvipat, P.M. Smith-Jones, D. Yoo, A. Kwon, T. Wasielewska, D. Welsbie, C.D. Chen, C.S. Higano, T.M. Beer, D.T. Hung, H.I. Scher, M.E. Jung, and C.L. Sawyers Development of a second-generation antiandrogen for treatment of advanced prostate cancer Science 324 5928 2009 787 790
73. H.H. Fiebig, D.P. Berger, B.R. Winterhalter, and J. Plowman In vitro and in vivo evaluation of US-NCI compounds in human tumor xenografts Cancer Treat. Rev. 17 2-3 1990 109 117
74. P. Carter, L. Presta, C.M. Gorman, J.B. Ridgway, D. Henner, W.L. Wong, A.M. Rowland, C. Kotts, M.E. Carver, and H.M. Shepard Humanization of an anti-p185HER2 antibody for human cancer therapy Proc. Natl. Acad. Sci. U.S.A. 89 10 1992 4285 4289
75. M.C. Villarroel, N.V. Rajeshkumar, I. Garrido-Laguna, A. De Jesus-Acosta, S. Jones, A. Maitra, R.H. Hruban, J.R. Eshleman, A. Klein, D. Laheru, R. Donehower, and M. Hidalgo Personalizing cancer treatment in the age of global genomic analyses: PALB2 gene mutations and the response to DNA damaging agents in pancreatic cancer Mol. Cancer Ther. 10 1 2011 3 8
76. K. Garber From human to mouse and back: 'tumorgraft' models surge in popularity J. Natl. Cancer Inst. 101 1 2009 6 8
77. C. Kumar-Sinha, S.A. Tomlins, and A.M. Chinnaiyan Recurrent gene fusions in prostate cancer Nat. Rev. Cancer 8 7 2008 497 511
78. S.M. Falzarano, M. Zhou, P. Carver, T. Tsuzuki, K. Simmerman, H. He, and C. Magi-Galluzzi ERG gene rearrangement status in prostate cancer detected by immunohistochemistry Virchows Arch. 2011
79. K. Park, S.A. Tomlins, K.M. Mudaliar, Y.L. Chiu, R. Esgueva, R. Mehra, K. Suleman, S. Varambally, J.C. Brenner, T. MacDonald, A. Srivastava, A.K. Tewari, U. Sathyanarayana, D. Nagy, G. Pestano, L.P. Kunju, F. Demichelis, A.M. Chinnaiyan, and M.A. Rubin Antibody-based detection of ERG rearrangement- positive prostate cancer Neoplasia 12 7 2010 590 598
80. A. Chaux, R. Albadine, A. Toubaji, J. Hicks, A. Meeker, E.A. Platz, A.M. De Marzo, and G.J. Netto Immunohistochemistry for ERG expression as a surrogate for TMPRSS2-ERG fusion detection in prostatic adenocarcinomas Am. J. Surg. Pathol. 35 7 2011 1014 1020